2023年10月22日 · 2020 年，美国放射学会（ACR）正式发布了卵巢 - 附件影像报告和数据系统（O-RADS）超声风险分层与管理的共识指南。 该共识指南是ACR 超声工作小组在 2018 年发表的白皮书 O-RADS超声词典的基础上推出的，为卵巢肿瘤的良恶性诊断和管理提供依据。 通过观察卵巢肿块的大小、形态、内部结构、有无包膜、 有无分隔、有无乳头突起、肿块血流信号情况，并对 照 O-RADS 分类诊断标准及风险评估表对肿块依次分为 O-RADS 0 类、1 类、2 类、3 类、4 …

2024年12月20日 · The Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) forms the ultrasound component of the Ovarian-Adnexal Reporting and Data System (O-RADS). This system aims to ensure that there are uniform unambiguous sonographic evaluations of ovarian or other adnexal lesions, accurately assigning each lesion to a risk category of ...

The Ovarian-Adnexal Reporting and Data System (O-RADS) US risk stratification and management system is designed to provide consistent interpretations, to decrease or eliminate ambiguity in US reports resulting in a higher probability of accuracy in assigning risk of malignancy to ovarian and other adnexal masses, and to provide a management ...

2020年12月23日 · Color score (CS) is important for appropriate Ovarian-Adnexal Reporting and Data System (O-RADS) categorization of multilocular cystic lesions with solid components. Color Doppler imaging shows very strong flow (CS 4) consistent with O-RADS category 5 lesion. Size is irrelevant for risk stratification of lesions with these features.

O-RADS™ is a clinical support system for the standardized description and classification of ovarian/adnexal lesions. The system consists of two complementary arms: Ultrasound (US) — the primary imaging modality, which is optimized for high sensitivity. Magnetic Resonance Imaging (MRI) — a secondary tool that allows higher specificity.

The O-RADS Ultrasound lexicon offers imaging and clinical management recommendations with risk assessment categories to optimize patient outcomes.

2025年2月6日 · The O-RADS ultrasound calculator is a powerful tool that streamlines the assessment and management of adnexal masses. By promoting standardized reporting and risk stratification, it represents a significant step forward in improving patient outcomes and advancing research in ovarian and adnexal pathologies.

2023年6月4日 · O-RADS 3：恶性风险低的病变（1%至<10%），包括＞10cm的单房囊肿（单纯性/非单纯性）、典型的出血性囊肿、皮样囊肿、子宫内膜异位症，内壁不规则但壁厚<3m的单房囊肿（任何大小），<10cm的多房囊肿（内壁或分隔光滑，彩色评分/CS=1-3），以及任何大小的外形规则的无血管实性病变（CS=1）；。 O-RADS 4：具有中等恶性风险的病变（10% 至 <50%），包括多房囊肿（1.内壁光滑，≥10厘米，CS=1-3；2.内壁光滑，任何大 …

Results The O-RADS MRI score and modified O-RADS score showed sensitivity at 100.0% (95% CI, 95.7–100.0%) and 71.4% (95% CI, 60.5–80.8%), specificity at 12.5% (95% CI, 4.2–26.8%) and 75.0%...

2024年3月7日 · O-RADS is an acronym for Ovarian-Adnexal Reporting & Data System. It’s a system healthcare providers use to classify ovarian and adnexal lesions on ultrasound and MRI images. O-RADS helps providers across the U.S. interpret test results more reliably and consistently. It also reduces the risk of false ovarian cancer diagnoses. What is O-RADS?